0.50
0.50 (0%)
As of May 29, 2025
Nextcure, Inc. [NXTC]
Source:
Company Overview
Nextcure, Inc. is a clinical-stage biopharmaceutical company that is focused on advancing innovative medicines that treat cancer patients that do not respond to, or that have disease progression on current therapies, through the use of differentiated mechanisms of actions including Antibody-Drug Conjugates (“ADCs”).
Country | United States |
Headquarters | beltsville, maryland |
Phone Number | 240-399-4900 |
Industry | manufacturing |
CEO | Michael Richman |
Website | nextcure.com |